#New York #agentic AI #Hyro #Dr. Sindhu Pandit

Hyro Strengthens Leadership Team with New VP of Clinical Product Strategy

On June 4, 2026, Hyro, recognized for its commitment to responsible AI in the healthcare sector, made a significant addition to its leadership team by appointing Dr. Sindhu Pandit as Vice President of Clinical Product Strategy. Dr. Pandit, known for her extensive experience in both clinical environments and digital health innovation, is set to drive the integration of Agentic AI in healthcare settings, a development that promises to enhance clinical workflows and improve patient outcomes.

Dr. Pandit’s background is distinguished by a robust combination of clinical expertise and strategic oversight in healthcare operations. As a practicing physician at Ochsner Health System in New Orleans, she has first-hand experience in the clinical challenges that healthcare organizations face. Previous roles at Salesforce and Best Buy Health have further enriched her understanding of digital transformation in healthcare, producing a leader who is well-equipped to guide Hyro as it advances its clinical product strategy.

At Hyro, Dr. Pandit’s main objective will be to ensure the platform is tailored to meet the stringent operational and regulatory requirements specific to the healthcare sector. The increasing complexity of clinical use cases necessitates that health systems utilize advanced solutions like those provided by Hyro, which are designed expressly for regulated environments. Dr. Pandit’s expertise will be crucial as the company develops its roadmap, particularly in relation to analytics capabilities that can unlock valuable insights from patient interaction data.

In her new role, Dr. Pandit will act as a clinical authority, fostering trust and rapport with stakeholders across the healthcare spectrum. Her insight and leadership will be instrumental in refining Hyro's offerings to ensure they are not only effective in enhancing clinical decision-making but also capable of navigating the real-world complexities of healthcare delivery. “Healthcare organizations are adopting agentic AI for intricate workflows, and it needs to be designed with profound clinical informatics expertise,” Dr. Pandit remarked regarding her vision for Hyro’s future.

Israel Krush, CEO and Co-Founder of Hyro, expressed enthusiasm about Dr. Pandit’s appointment, noting the importance of bridging the divide between technical innovation and actual patient care. “Dr. Pandit brings a level of precision and clinical rigor that is essential as we scale our efforts to integrate agentic AI solutions within healthcare workflows,